Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Atrial fibrillation: review of current treatment strategies.

Xu J, Luc JG, Phan K.

J Thorac Dis. 2016 Sep;8(9):E886-E900. Review.

2.

Value of Implantable Loop Recorders in Monitoring Efficacy of Radiofrequency Catheter Ablation in Atrial Fibrillation.

Yang P, Pu L, Yang L, Li F, Luo Z, Guo T, Hua B, Li S.

Med Sci Monit. 2016 Aug 12;22:2846-51.

3.

Catheter ablation versus medical rate control for persistent atrial fibrillation in patients with heart failure: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.

Zhu M, Zhou X, Cai H, Wang Z, Xu H, Chen S, Chen J, Xu X, Xu H, Mao W.

Medicine (Baltimore). 2016 Jul;95(30):e4377. doi: 10.1097/MD.0000000000004377. Review.

4.

eComment. Spontaneous conversion from atrial fibrillation to typical atrial flutter during the operation.

Aparci M, Uz O, Atalay M.

Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):264. doi: 10.1093/icvts/ivv404. No abstract available.

5.

Totally thoracoscopic left atrial Maze: standardized, effective and safe.

Geuzebroek GS, Bentala M, Molhoek SG, Kelder JC, Schaap J, Van Putte BP.

Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):259-64. doi: 10.1093/icvts/ivv358. Epub 2015 Dec 23.

6.

Managing atrial fibrillation in the very elderly patient: challenges and solutions.

Karamichalakis N, Letsas KP, Vlachos K, Georgopoulos S, Bakalakos A, Efremidis M, Sideris A.

Vasc Health Risk Manag. 2015 Oct 27;11:555-62. doi: 10.2147/VHRM.S83664. eCollection 2015. Review.

7.

Perioperative atrial fibrillation: a systematic review of evolving therapeutic options in pharmacologic and procedural management.

Schleifer JW, Ramakrishna H.

Ann Card Anaesth. 2015 Oct-Dec;18(4):565-70. doi: 10.4103/0971-9784.166466. Review.

8.

Late outcomes after the Cox maze IV procedure for atrial fibrillation.

Henn MC, Lancaster TS, Miller JR, Sinn LA, Schuessler RB, Moon MR, Melby SJ, Maniar HS, Damiano RJ Jr.

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1168-76, 1178.e1-2. doi: 10.1016/j.jtcvs.2015.07.102. Epub 2015 Aug 8.

9.

Atrial fibrillation in heart failure: what should we do?

Kotecha D, Piccini JP.

Eur Heart J. 2015 Dec 7;36(46):3250-7. doi: 10.1093/eurheartj/ehv513. Epub 2015 Sep 28. Review.

10.

Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized Trial.

Theis C, Konrad T, Mollnau H, Sonnenschein S, Kämpfner D, Potstawa M, Ocete BQ, Bock K, Himmrich E, Münzel T, Rostock T.

Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1080-7. doi: 10.1161/CIRCEP.115.002786. Epub 2015 Aug 21.

11.
12.

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.

Cappato R, Marchlinski FE, Hohnloser SH, Naccarelli GV, Xiang J, Wilber DJ, Ma CS, Hess S, Wells DS, Juang G, Vijgen J, Hügl BJ, Balasubramaniam R, De Chillou C, Davies DW, Fields LE, Natale A; VENTURE-AF Investigators..

Eur Heart J. 2015 Jul 21;36(28):1805-11. doi: 10.1093/eurheartj/ehv177. Epub 2015 May 14.

13.

The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Darbar D.

J Cardiovasc Pharmacol. 2016 Jan;67(1):9-18. doi: 10.1097/FJC.0000000000000280. Review.

14.

Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation.

Bhave PD, Lu X, Girotra S, Kamel H, Vaughan Sarrazin MS.

Heart Rhythm. 2015 Jul;12(7):1406-12. doi: 10.1016/j.hrthm.2015.03.031. Epub 2015 Mar 23.

15.

Sequential hybrid procedure for persistent atrial fibrillation.

Bulava A, Mokracek A, Hanis J, Kurfirst V, Eisenberger M, Pesl L.

J Am Heart Assoc. 2015 Mar 25;4(3):e001754. doi: 10.1161/JAHA.114.001754.

16.

Low contact force and force-time integral predict early recovery and dormant conduction revealed by adenosine after pulmonary vein isolation.

le Polain de Waroux JB, Weerasooriya R, Anvardeen K, Barbraud C, Marchandise S, De Meester C, Goesaert C, Reis I, Scavee C.

Europace. 2015 Jun;17(6):877-83. doi: 10.1093/europace/euu329. Epub 2015 Jan 24.

17.

Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation.

Park J, Kim TH, Lee JS, Park JK, Uhm JS, Joung B, Lee MH, Pak HN.

J Am Heart Assoc. 2014 Oct 7;3(5):e001277. doi: 10.1161/JAHA.114.001277.

19.

How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?

Sankaranarayanan R, Kirkwood G, Visweswariah R, Fox DJ.

Curr Cardiol Rev. 2015;11(3):190-8. Review.

20.

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?

Lip GY, Al-Khatib SM, Cosio FG, Banerjee A, Savelieva I, Ruskin J, Blendea D, Nattel S, De Bono J, Conroy JM, Hess PL, Guasch E, Halperin JL, Kirchhof P, Cosio MD, Camm AJ.

J Am Heart Assoc. 2014 Aug 27;3(4). pii: e001179. doi: 10.1161/JAHA.114.001179. Review. No abstract available.

Supplemental Content

Loading ...
Support Center